A comprehensive view of Capsules/Pills/Tablets. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Dr. Reddy's acquires trademark rights from Pfizer for Primcyv breast cancer drug as an oral capsule in India; Dr. Reddy's to manufacture Primcyv’s active pharmaceutical ingredient and finished drug at its FDA-approved state-of-the-art facilities
Published: January 16, 2023 by BioSpectrum India
Novo Nordisk announces FDA approval of label update for Rybelsus allowing use as a first-line option for adults with type 2 diabetes
Published: January 13, 2023 by ENP Newswire
Pfizer listed a new clinical trial to compare two different oral forms of PF-07081532 in adults who are overweight or obese
Published: January 11, 2023 by Contify Life Science News
AstraZeneca and MSD’s Lynparza tablets combined with abiraterone and prednisone or prednisolone now approved in the EU for treatment of metastatic castration-resistant prostate cancer
Published: December 21, 2022 by AstraZeneca AB
Kyowa Kirin divests 13 mature brands to Grunenthal in deal worth US$83.0M, plus royalties; products include Abstral fentanyl sublingual tablets, PecFent fentanyl nasal spray, Moventig naloxegol, Adcal-D3 calcium and vitamin D3 for osteoporosis
Published: November 29, 2022 by Outsourcing-Pharma.com

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count